Kraus, Marianne
80  results:
Search for persons X
?
7

P-091: Genome-wide CRISPR/Cas9 screening identifies proteas..:

Andrej, Besse ; Lenka, Besse ; Büchler, Lorina...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S88-S89 , 2021
 
?
8

Nelfinavir interacts with mitochondrial VDACs and disrupts ..:

Besse, Andrej ; Besse, Lenka ; Stolze, Sara Christina...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e125-e126 , 2019
 
?
9

Novel cell line models to study mechanisms and overcoming s..:

Brünnert, Daniela ; Kraus, Marianne ; Stühmer, Thorsten...
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.  1865 (2019)  6 - p. 1666-1676 , 2019
 
?
10

Expression of MDR1 Mediates Carfilzomib Resistance in MM an..:

Besse, Andrej ; Besse, Lenka ; Stolze, Sara C....
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e32 , 2017
 
?
13

EDO-S101, an Alkylating-HDAC-Inhibitor, is Synergistic With..:

Besse, Lenka ; Kraus, Marianne ; Besse, Andrej...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e31-e32 , 2017
 
?
14

A Set of Activity‐Based Probes to Visualize Human (Immuno)p..:

de Bruin, Gerjan ; Xin, Bo Tao ; Kraus, Marianne...
Angewandte Chemie International Edition.  55 (2015)  13 - p. 4199-4203 , 2015
 
?
15

The novel β2-selective proteasome inhibitor LU-102 decrease..:

Kraus, Johannes ; Kraus, Marianne ; Liu, Nora...
Cancer Chemotherapy and Pharmacology.  76 (2015)  2 - p. 383-396 , 2015
 
1-15